Meeder Asset Management Inc Immunic, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$11.74 - $22.0 $3,134 - $5,874	-267 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$5.67 - $15.86 $567 - $1,586	-100 Reduced 27.25%	267 $3,000
Q1 2020 May 15, 2020	BUY	$4.22 - $9.8 $654 - $1,519	155 Added 73.11%	367 $2,000
Q4 2019 Feb 13, 2020	BUY	$6.4 - $10.23 $428 - $685	67 Added 46.21%	212 $2,000
Q3 2019 Oct 17, 2019	SELL	$10.0 - $17.01 $150 - $255	-15 Reduced 9.38%	145 $1,000
Q2 2019 Aug 05, 2019	BUY	$7.88 - $33.2 $1,260 - $5,312	160 New	160 $2,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33.3M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.